Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV LPS challenge study of neuroinflammatory biomarkers in CSF and blood in healthy male volunteers
NL-OMON57284Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of lipopolysaccharide endotoxin, sponsored by Centre for Human Drug Research. Primary endpoints: Central inflammatory response in CSF, Systemic inflammatory response in blood and 1 more. Started Feb 2025; status: completed.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NL-OMON57284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57284.